Possible ruxolitinib-induced acquired epidermodysplasia verruciformis and multiple non-melanoma skin cancers in a patient with polycythemia vera

J Cosmet Dermatol. 2022 Nov;21(11):6502-6503. doi: 10.1111/jocd.15253. Epub 2022 Aug 9.
No abstract available

Publication types

  • Letter

MeSH terms

  • Epidermodysplasia Verruciformis* / diagnosis
  • Humans
  • Polycythemia Vera* / drug therapy
  • Skin
  • Skin Neoplasms* / chemically induced
  • Skin Neoplasms* / drug therapy

Substances

  • ruxolitinib